An efficient protein transformation protocol for introducing prions into yeast

被引:37
作者
Tanaka, Motomasa [1 ]
Weissman, Jonathan S. [1 ]
机构
[1] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA
来源
AMYLOID, PRIONS, AND OTHER PROTEIN AGGREGATES, PT B | 2006年 / 412卷
基金
美国国家卫生研究院; 日本学术振兴会;
关键词
D O I
10.1016/S0076-6879(06)12012-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Although a range of robust techniques exists for transforming organisms with nucleic acids, approaches for introducing proteins into cells are far less developed. Here we describe a facile and highly efficient protein transformation protocol suitable for introducing prion particles, produced in vitro from pure protein or purified from an in vivo source, into yeast. Prion particles composed of amyloid forms of fragments of Sup35p, the protein determinant of the yeast prion state [PSI+], lead to dose-dependent de novo induction of [PSI+] with efficiencies approaching 100% at high protein concentrations. We also describe a procedure for generating distinct, self-propagating amyloid conformations of a prionogenic Sup35p fragment termed Sup-NM. Remarkably, infection of yeast with different Sup-NM amyloid conformations leads to distinct [PSI+] prion strains, establishing that the heritable differences in prion strain differences result directly from self-propagating differences in the conformations of the infectious protein. This protein transformation protocol can be readily adapted to the analysis of other yeast prion states, as well as to test the infectious (prion) nature of protein extracts from less well-characterized epigenetic traits. More generally, the protein transformation procedure makes it possible to bridge in vitro and in vivo studies, thus greatly facilitating efforts to explain the structural and mechanistic basis of prion inheritance.
引用
收藏
页码:185 / 200
页数:16
相关论文
共 46 条
[1]   Understanding the diversity of prions [J].
Aguzzi, A .
NATURE CELL BIOLOGY, 2004, 6 (04) :290-292
[2]   Architecture of Ure2p prion filaments - The N-terminal domains form a central core fiber [J].
Baxa, U ;
Taylor, KL ;
Wall, JS ;
Simon, MN ;
Cheng, NQ ;
Wickner, RB ;
Steven, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (44) :43717-43727
[3]   Structure and assembly properties of the yeast prion Ure2p [J].
Bousset, L ;
Thual, C ;
Belrhali, H ;
Morera, S ;
Melki, R .
COMPTES RENDUS BIOLOGIES, 2002, 325 (01) :3-8
[4]   Prion generation in vitro:: amyloid of Ure2p is infectious [J].
Brachmann, A ;
Baxa, U ;
Wickner, RB .
EMBO JOURNAL, 2005, 24 (17) :3082-3092
[5]   The Sup35 domains required for maintenance of weak, strong or undifferentiated yeast [PSI+] prions [J].
Bradley, ME ;
Liebman, SW .
MOLECULAR MICROBIOLOGY, 2004, 51 (06) :1649-1659
[6]   ROLE OF THE CHAPERONE PROTEIN HSP104 IN PROPAGATION OF THE YEAST PRION-LIKE FACTOR [PSI(+)] [J].
CHERNOFF, YO ;
LINDQUIST, SL ;
ONO, B ;
INGEVECHTOMOV, SG ;
LIEBMAN, SW .
SCIENCE, 1995, 268 (5212) :880-884
[7]   Emerging principles of conformation based prion inheritance [J].
Chien, P ;
Weissman, JS ;
DePace, AH .
ANNUAL REVIEW OF BIOCHEMISTRY, 2004, 73 :617-656
[8]   Generation of prion transmission barriers by mutational control of amyloid conformations [J].
Chien, P ;
DePace, AH ;
Collins, SR ;
Weissman, JS .
NATURE, 2003, 424 (6951) :948-951
[9]   Prion diseases of humans and animals: Their causes and molecular basis [J].
Collinge, J .
ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 :519-550
[10]   Mechanism of prion propagation: Amyloid growth occurs by monomer addition [J].
Collins, SR ;
Douglass, A ;
Vale, RD ;
Weissman, JS .
PLOS BIOLOGY, 2004, 2 (10) :1582-1590